FDA Tightens Rules on Copycat Ozempic and Wegovy – No More Routine Compounding
FDA limits copycat GLP-1 drugs; pharmacies can only make them during shortages. Original meds like Foundayo now safer & more available.
/ 1659 items
#XY↓
ALTO-101 Misses Primary Endpoint in Schizophrenia Trial, Company Shifts Focus to ALTO-207
ALTO-101 misses Phase 2 endpoints but shows signals. Alto pivots to ALTO-207 in treatment-resistant depression with strong prior data.
Connect Biopharma Insider Buying: Panacea Venture Adds 1.16M Shares
Director James Huang and Panacea Venture bought 1.16 million shares of Connect Biopharma at $3.45, boosting their stake to 21.2%.
FDA Delays Popular Nicotine Pouches Over Youth Risks
Popular nicotine pouches like Zyn and Velo remain unapproved in the US despite FDA fast-track. Agency hesitates due to rising youth use and addiction concerns.
FDA Just Approved Foundayo: The Only GLP-1 Weight-Loss Pill You Can Take Anytime, Anywhere
Eli Lilly’s Foundayo (orforglipron) is now FDA-approved — the only GLP-1 pill for weight loss you can take any time of day, with or without food or water. Average 27 lb loss.
Cyclerion Stock Soars on $380M Merger with Korsana to Fight Alzheimer’s
Cyclerion stock surges after announcing a merger with Korsana Biosciences and $380M in new funding to advance a next-gen Alzheimer’s antibody.